Company expands recall for potassium tablets

Company expands recall for potassium tablets Photo: FDA

January 03, 2019 03:42 PM

Torrent Pharmaceuticals Limited has expanded a recall of its Losartan potassium tablets due to the presence of a "probable human carcinogen." 

According to the FDA, the company has recalled 10 different varieties of potassium tablets. You can see the full list of the products that were recalled here. 


The FDA reports the tablets contain N-nitrosodiethylamine, a probable human carcinogen, above the acceptable daily level. 

More from KSTP

The tablets were distributed nationwide, according to the recall. 

The potassium tablets are used to treat hypertension and neropathy in Type 2 diabetic patients.

Those who use the tablets are asked to continue to use the medication, as "the risk of harm to the patient's health may be higher if the treatment is stopped immediately without any alternative treatment." Patients are asked to contact their pharmacists or doctors about alternative treatments. 

Consumers with questions about the recall are asked to call 1-888-280-2040. 


Connect with KSTP

Join the conversation on our social media platforms. Share your comments on our Facebook, Instagram, and Twitter pages.



Copyright 2019 - KSTP-TV, LLC A Hubbard Broadcasting Company


Major traffic delays Monday for drivers along I-494 in the southeast metro

Report: 11 Minnesota nursing homes in need of greater oversight

8-year-old Big Lake girl raises money for family devastated by deadly house fire

2 U of M Gopher wrestlers being held on suspicion of criminal sexual conduct